BEIJING TONG REN TANG CHINESE MEDICINE COMPANY LIMITED

Andere Sprachen Beijing Tong Ren Tang Chinese Medicine Company Limited Deutsche Boerse AG

Aktien

A1XDB1

HK0000145638

TQR

Markt geschlossen - Deutsche Boerse AG Andere Börsenplätze 08:11:40 31.05.2024			% 5 Tage	% 1. Jan.
1,13 ^EUR	+0,89 %		-.--%	-18,71 %

13.05.	Tong Ren Tang Chinesische Medizin ernennt CEO	MT
10.05.	Beijing Tong Ren Tang Chinese Medicine Company Limited ernennt Wang Chi zum Executive Director und Mitglied des Competition Executive Committee	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Tong Ren Tang Chinese Medicine Appoints CEO	13.05.
Beijing Tong Ren Tang Chinese Medicine Company Limited Appoints Wang Chi as an Executive Director and a Member of the Competition Executive Committee	10.05.
Beijing Tong Ren Tang Chinese Medicine Company Limited Announces CEO Changes	10.05.
Beijing Tong Ren Tang Gets Nod to Sell Fever Drug in Hong Kong	30.04.
Beijing Tong Ren Tang Chinese Medicine Company Limited Announcement on Receiving the Certificate of Registration of Proprietary Chinese Medicine	30.04.
Beijing Tong Ren Tang Chinese Medicine CEO Steps Down; Acting CEO Appointed	29.03.
Beijing Tong Ren Tang Chinese Medicine Company Limited Announces CEO Changes	28.03.
Beijing Tong Ren Tang Chinese Medicine Company Limited Announces Resignation of Yu Jin as an Executive Director and Member of the Competition Executive Committee	28.03.
Beijing Tong Ren Tang Chinese Medicine's Profit Falls on Lower Revenue	15.03.
Beijing Tong Ren Tang Chinese Medicine Signs E-Commerce Framework Agreement	15.03.
Beijing Tong Ren Tang Chinese Medicine Company Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 24 June 2024	14.03.
Beijing Tong Ren Tang Chinese Medicine Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	14.03.
Beijing Tong Ren Tang Flags Up to 22% Profit Drop in 2023	29.01.
Beijing Tong Ren Tang Chinese Medicine Company Limited Provides Earnings Guidance for the Year Ended 31 December 2023	29.01.
Beijing Tong Ren Tang Chinese Medicine Company Limited Appoints Gu Hai Ou as Executive Director, Chairman of Board and Authorised Representative	13.12.
Beijing Tong Ren Tang Chinese Medicine Company Limited Proposes New Exclusive Distributorship Framework Agreements	29.11.
Chinese listed firms used endangered animal parts as ingredients -report	23.10.23
Three listed Chinese firms used endangered animal parts as ingredients- report	23.10.23
Beijing Tong Ren Tang Chinese Medicine Company Limited Appoints Mr. Yu Jin as Executive Director and A Member of Competition Executive Committee	20.10.23
Sinopharm CFO Retires; Successor Named	16.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Beijing Tong Ren Tang Chinese Medicine Company Limited Deutsche Boerse AG

Aktien

A1XDB1

HK0000145638

TQR

Andere Sprachen

Filter